Rite Aid logo

RAD - Rite Aid Share Price

$16.14 -1.3  -7.2%

Last Trade - 20/09/21

Consumer Defensives
Mid Cap
Market Cap £697.5m
Enterprise Value £2.82bn
Revenue £17.59bn
Position in Universe 3017th / 7145
Unlock RAD Revenue
Relative Strength (%)
1m +9.99%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -46.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 27th Feb 2016 2017 2018 2019 2020 2021 2022E 2023E CAGR / Avg
20,770 22,928 21,529 21,640 21,928 24,043 25,160 25,138 +3.0%
-93.1 -80.8
Balance Sheet
FINANCIAL BRIEF: : For the 13 weeks ended 29 May 2021, Rite AidCorporation revenues increased 2% to $6.16B. Net lossbefore extraordinary items decreased 82% to $13.1M.Revenues reflect Retail pharmacy segment increase of 6% to$4.35B, Comp. Store Sales (Growth - %) -Pharmacy increasefrom 2.2 to 8.2%, Retail Sales, Total increase of 6% to$4.35B. Lower net loss reflects Merchandise Margins, Total-% increase of 3% to 26.9%.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


RAD Revenue Unlock RAD Revenue

Net Income

RAD Net Income Unlock RAD Revenue

Normalised EPS

RAD Normalised EPS Unlock RAD Revenue

PE Ratio Range

RAD PE Ratio Range Unlock RAD Revenue

Dividend Yield Range

RAD Dividend Yield Range Unlock RAD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
RAD EPS Forecasts Unlock RAD Revenue
Profile Summary

Rite Aid Corporation is a healthcare company that operates retail drugstore chain. The Company is principally engaged in providing its service to customers and communities through various programs. Its business segments include Retail Pharmacy segment and Pharmacy Services segment. Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. Its Retail Pharmacy segment operates approximately 2,500 retail pharmacy locations across 19 states. Pharmacy Services segment provides a range of pharmacy benefit services through Elixir. Elixir also offers integrated mail-order and specialty pharmacy services through Elixir Pharmacy. The Pharmacy Services segment provides both transparent and traditional pharmacy benefit management (PBM) options through its Elixir PBM. The Company's clients include employers, insurance companies and unions.

Last Annual February 27th, 2021
Last Interim May 29th, 2021
Incorporated April 15, 1968
Public Since May 22, 1981
No. of Shareholders: 9,652
No. of Employees: 50,000
Sector Consumer Defensives
Industry Food & Drug Retailing
Exchange New York Stock Exchange
Shares in Issue 55,086,812
Free Float (0.0%)
Eligible for
RAD Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for RAD
Upcoming Events for RAD
Thursday 23rd September, 2021
Q2 2022 Rite Aid Corp Earnings Call
Thursday 23rd September, 2021
Q2 2022 Rite Aid Corp Earnings Release
Wednesday 15th December, 2021 Estimate
Q3 2022 Rite Aid Corp Earnings Release
Frequently Asked Questions for Rite Aid
What is the Rite Aid share price?

As of 20/09/21, shares in Rite Aid are trading at $16.14, giving the company a market capitalisation of £697.5m. This share price information is delayed by 15 minutes.

How has the Rite Aid share price performed this year?

Shares in Rite Aid are currently trading at $16.14 and the price has moved by 31.72% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Rite Aid price has moved by -2.27% over the past year.

What are the analyst and broker recommendations for Rite Aid?

Of the analysts with advisory recommendations for Rite Aid, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Rite Aid is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Rite Aid next release its financial results?

Rite Aid is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-05-29
What is the Rite Aid dividend yield?

Rite Aid does not currently pay a dividend.

Does Rite Aid pay a dividend?

Rite Aid does not currently pay a dividend.

When does Rite Aid next pay dividends?

Rite Aid does not currently pay a dividend.

How do I buy Rite Aid shares?

To buy shares in Rite Aid you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Rite Aid?

Shares in Rite Aid are currently trading at $16.14, giving the company a market capitalisation of £697.5m.

Where are Rite Aid shares listed? Where are Rite Aid shares listed?

Here are the trading details for Rite Aid:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: RAD
What kind of share is Rite Aid?

Based on an overall assessment of its quality, value and momentum, Rite Aid is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Rite Aid share price forecast 2021?

Shares in Rite Aid are currently priced at $16.14. At that level they are trading at 25.29% premium to the analyst consensus target price of 0.00.

Analysts covering Rite Aid currently have a consensus Earnings Per Share (EPS) forecast of -0.587 for the next financial year.

How can I tell whether the Rite Aid share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rite Aid. Over the past six months, the relative strength of its shares against the market has been -39.49%. At the current price of $16.14, shares in Rite Aid are trading at -7.71% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Rite Aid PE Ratio?

We were not able to find PE ratio data for Rite Aid.

Who are the key directors of Rite Aid?

Rite Aid's management team is headed by:

Bruce Bodaken - NEC
Kevin Lofton - IND
Matthew Schroeder - CFO
Jocelyn Konrad - EVP
Robert Knowling - IND
Justin Mennen - EVP
Brian Hoover - CAO
Elizabeth Burr - IND
Erik Keptner - SVP
Heyward Donigan - PRE
Andre Persaud - OTH
Paul Gilbert - EVP
Bari Harlam - IND
Jessica Kazmaier - CHO
Lance Neill - COO
Who are the major shareholders of Rite Aid?

Here are the top five shareholders of Rite Aid based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 9.32% (5.13m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 6.8% (3.75m shares)
Invesco Advisers, Inc. Investment Advisor
Percentage owned: 4.57% (2.52m shares)
Invesco Global Opportunities Fund Mutual Fund
Percentage owned: 4.54% (2.50m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 3.08% (1.70m shares)
Similar to RAD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.